BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 14164891)

  • 1. INTRATYPIC SERODIFFERENTIATION TESTS ON POLIO TYPE 1 VIRUS STRAINS ISOLATED BEFORE AND AFTER VACCINATION WITH ATTENUATED SABIN TYPE 1 POLIO VACCINE.
    HAHNEMANN F; SIBONI K; GODTFREDSEN A
    Acta Pathol Microbiol Scand; 1964; 61():437-45. PubMed ID: 14164891
    [No Abstract]   [Full Text] [Related]  

  • 2. GENETIC MARKERS OF POLIOVIRUS STRAINS ISOLATED FROM PARALYTIC PATIENTS PRIOR TO AND AFTER SABIN VACCINATION PROGRAMS. I. STUDIES ON TYPE 1 STRAINS.
    FURESZ J; ARMSTRONG RE; YAROSH W; NAGLER FP
    Am J Hyg; 1964 Jul; 80():45-54. PubMed ID: 14192769
    [No Abstract]   [Full Text] [Related]  

  • 3. GENETIC MARKERS OF POLIOVIRUS STRAINS ISOLATED FROM PARALYTIC PATIENTS PRIOR TO AND AFTER SABIN VACCINATION PROGRAMS. II. STUDIES ON TYPE 3 STRAINS.
    FURESZ J; ARMSTRONG RE; MOREAU P; NAGLER FP
    Am J Hyg; 1964 Jul; 80():55-61. PubMed ID: 14192770
    [No Abstract]   [Full Text] [Related]  

  • 4. ANTIGENIC VARIATIONS AMONG TYPE III POLIOMYELITIS VIRUSES.
    DEIBEL R; MACDONALD D
    N Y State J Med; 1964 Aug; 64():2058-65. PubMed ID: 14180893
    [No Abstract]   [Full Text] [Related]  

  • 5. MARKER TEST OF POLIOVIRUS IN RELATION TO MASS VACCINATION WITH LIVE ORAL VACCINES.
    TOYOSHIMA K; MITSUDA B; TADOKORO J; YAMADA T; KUNITA N
    Biken J; 1963 Jul; 6():57-72. PubMed ID: 14147706
    [No Abstract]   [Full Text] [Related]  

  • 6. [STUDIES ON TESTING THE SAFETY OF INACTIVATED POLIOMYELITIS VACCINES. II. SV 40 IN INACTIVATED POLIOMYELITIS VACCINES].
    GUENTHER O; HOEVEL H; VON METTENHEIM
    Zentralbl Bakteriol Orig; 1963 Dec; 190():445-65. PubMed ID: 14166424
    [No Abstract]   [Full Text] [Related]  

  • 7. THE USE OF A MODIFIED WECKER TECHNIQUE FOR SERODIFFERENTIATION OF TYPE 1 POLIOVIRUSES RELATED AND UNRELATED TO SABIN'S VACCINE STRAIN. II. ANTIGENIC SEGREGATION OF ISOLATES FROM SPECIMENS COLLECTED IN FIELD STUDIES.
    NAKANO JH; GELFAND HM; COLE JT
    Am J Hyg; 1963 Sep; 78():214-26. PubMed ID: 14063724
    [No Abstract]   [Full Text] [Related]  

  • 8. [WHAT DOES THE TESTING OF VIRAL VACCINES DO FOR THE HARMLESSNESS OF VACCINES IN THEIR PRACTICAL USE?].
    BONIN O; GUENTHER O
    Med Welt; 1964 Apr; 15():822-31. PubMed ID: 14194499
    [No Abstract]   [Full Text] [Related]  

  • 9. THE TYPING OF ENTEROVIRUSES IN TISSUE CULTURE BY NEUTRALIZATION WITH COMPOSITE ANTISERUM POOLS.
    HAMBLING MH; DAVIS PM; MACRAE AD
    J Hyg (Lond); 1963 Dec; 61(4):479-84. PubMed ID: 14103547
    [No Abstract]   [Full Text] [Related]  

  • 10. [ON THE VIABILITY AND RESISTANCE OF VACCINAL STRAINS OF POLIOVIRUSES IN THE EXTERNAL ENVIRONMENT].
    BYCHKOVSKAIA OV; BABINA NS; IVANOVA OD; KISELEVA LF
    Gig Sanit; 1964 Aug; 29():45-9. PubMed ID: 14249261
    [No Abstract]   [Full Text] [Related]  

  • 11. CHARACTERISTICS OF SABIN TYPE 1 POLIOVIRUS AFTER GASTROINTESTINAL PASSAGE IN NEWBORN INFANTS. II. ANTIGENICITY AND ELUTION FROM AL(OH)3 GEL.
    WOODS WA; ROBBINS FC; WEISS RA; CASHEL J; KIRSCHSTEIN RL
    Am J Hyg; 1964 Mar; 79():236-44. PubMed ID: 14131876
    [No Abstract]   [Full Text] [Related]  

  • 12. [OBSERVATIONS ON THE CULTURE OF POLIOVIRUS STRAINS FROM THE BLOOD AFTER VACCINATION WITH SABIN VACCINE L SC 2 AB].
    GRUETZNER L
    Zentralbl Bakteriol Orig; 1963 Dec; 191():90-1. PubMed ID: 14119947
    [No Abstract]   [Full Text] [Related]  

  • 13. THERMORESISTANCE TESTING FOR IDENTIFICATION OF LSC 2AB VIRUS PROGENY.
    JANDA Z; VONKA V
    Arch Gesamte Virusforsch; 1964; 14():227-37. PubMed ID: 14141582
    [No Abstract]   [Full Text] [Related]  

  • 14. THE PROPERTIES OF A NEW TYPE 3 ATTENUATED POLIOVIRUS. I. DERIVATION OF NEW TYPE 3 ATTENUATED POLIOVIRUSES AND THEIR LABORATORY CHARACTERISTICS.
    VONKA V; JANDA Z; SIMON J
    Arch Gesamte Virusforsch; 1964 Jun; 14():599-610. PubMed ID: 14247356
    [No Abstract]   [Full Text] [Related]  

  • 15. RESULTS OF INVESTIGATION OF TYPE 1 VIRUSES ISOLATED FROM PARALYTIC PATIENTS IN THE PERIOD FOLLOWING MASS VACCINATION WITH SABIN'S VACCINE IN CZECHOSLOVAKIA IN 1960.
    VONKA V; JANDA Z; SIMON J; ADAM E; ZAVADOVA H
    J Hyg Epidemiol Microbiol Immunol; 1964; 8():58-76. PubMed ID: 14128980
    [No Abstract]   [Full Text] [Related]  

  • 16. ANTIGENIC DIFFERENTIATION OF POLIOVIRUSES BY ABSORBED HYPERIMMUNE SERA. I. ANTIGENIC DIFFERENTIATION OF TYPE I STRAINS OF DIVERSE ORIGIN.
    EYLAN E; FOGEL A; DUKLER R; RANNON L
    J Immunol; 1965 Jul; 95():171-80. PubMed ID: 14328695
    [No Abstract]   [Full Text] [Related]  

  • 17. CONVENTIONAL TISSUE CULTURE NEUTRALIZATION TECHNIQUE EMPLOYED IN SERODIFFERENTIATION BETWEEN TYPE 1 POLIOVIRUSES.
    HAHNEMANN F; SIBONI K
    Acta Pathol Microbiol Scand; 1964; 61():75-80. PubMed ID: 14150637
    [No Abstract]   [Full Text] [Related]  

  • 18. [ON THE LOSS OF NEUTRALIZING PROPERTIES OF POLIOMYELITIS VIRUS IN THE COURSE OF ITS ADSORPTION IN EPITHELIAL KIDNEY CELLS OF M. RHESUS].
    LANGE A; ZUR HAUSEN
    Z Hyg Infektionskr; 1964 Dec; 150():179-84. PubMed ID: 14335617
    [No Abstract]   [Full Text] [Related]  

  • 19. A STUDY OF SABIN TYPE 1 ORAL VACCINE VIRUS DURING FIVE HUMAN PASSAGES.
    PAVILANIS V; LUSSIER G; FOLEY AR; CHARBONNEAU JH; DIFRANCO E; DUBREUIL R
    Rev Can Biol; 1964 Sep; 23():265-76. PubMed ID: 14237159
    [No Abstract]   [Full Text] [Related]  

  • 20. ENTEROVIRUS TYPING BY COMPLEMENT FIXATION.
    GNESH GM; PLAGER H; DECHER W
    Proc Soc Exp Biol Med; 1964 Apr; 115():898-900. PubMed ID: 14166601
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.